Stockreport

ImmuCell reports preliminary Q1 sales, stock climbs 7% [Seeking Alpha]

ImmuCell Corporation  (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
PDF The animal health company said sales jumped 111% year-over-year to $7.3M for the quarter ended March 31, 2024. Sales for the 12-month period ended March 31 rose 33% to [Read more]